From the list Jordi provided to us on think tanks, I clicked on the link to the Harvard Kennedy School of Government, which allowed me to search the topic of my choice. Since I am interested in the ethics of a potential US organ market, I typed in “organ market,” and came across an article from a think tank source called the Competitive Enterprise Institute (CEI). CEI is a “non-profit public policy organization dedicated to advancing the principles of limited government, free enterprise, and individual liberty.” They fight for a lot of issues at the state, national and international levels. The organization addresses many issues, including energy, environment, business and finance, technology, telecommunications, and food and drug regulation.
My search led me to this article by Jennifer Monti published in 2009 by CEI. She asserts that the issue over an organ market stems from a lack of supply of organ donors. The donor system, Monti says, is unreliable because there are no consistent sources of potential donors. In 2009, she says, “approximately 73,000 people sit on the waiting list for a kidney—18 of them will die by tomorrow and 6,000 more patients join the list every year.” This clearly describes an issue that needs attention. The National Organ Transplant Act of 1984 (NOTA) directly prohibits the sale of organs in the US, making new regulation necessary for any potential legal organ market. In the article, Monti is pro-organ market. She claims it will save lives, be safer, and make organ transplantation more efficient. I am not sure yet where I will stand on this issue after thorough research but as of now I agree with Monti.
Some recent examples of a successful organ market exist in Iran and Singapore. They can teach us a lot about how the US can form its own organ market. It seems that an organ market would be a win-win for both donors and recipients.